Advanced search
Publication Cover
Clinical, Cosmetic and Investigational Dermatology Volume 16, 2023 - Issue
Submit an article Journal homepage
227
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Refractory Bullous Systemic Lupus Erythematosus Successfully Treated with Rituximab: A Case Report and Literature Review

Yanisa RatanapokasatitDivision of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, ThailandORCID Iconhttps://orcid.org/0000-0001-8303-3323
ORCID Icon,
Chutima Seree-AphinanDivision of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, ThailandORCID Iconhttps://orcid.org/0000-0002-8244-0098
ORCID Icon &
Kumutnart ChanprapaphDivision of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, ThailandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7931-3816
ORCID Icon
Pages 883-890 | Received 06 Jan 2023, Accepted 25 Mar 2023, Published online: 04 Apr 2023

References

  • Contestable JJ, Edhegard KD, Meyerle JH. Bullous systemic lupus erythematosus: a review and update to diagnosis and treatment. Am J Clin Dermatol. 2014;15(6):517–524. doi:10.1007/s40257-014-0098-0
  • Alsanafi S, Kovarik C, Mermelstein AL, Werth VP. Rituximab in the treatment of bullous systemic lupus erythematosus. J Clin Rheumatol. 2011;17(3):142–144. doi:10.1097/RHU.0b013e318214f30c
  • Tincopa M, Puttgen KB, Sule S, Cohen BA, Gerstenblith MR. Bullous lupus: an unusual initial presentation of systemic lupus erythematosus in an adolescent girl. Pediatr Dermatol. 2010;27(4):373–376. doi:10.1111/j.1525-1470.2010.01179.x
  • Lowe CD, Brahe CA, Green B, Lam TK, Meyerle JH. Bullous systemic lupus erythematosus successfully treated with rituximab. Cutis. 2019;103(6):E5–E7.
  • Duan L, Chen L, Zhong S, et al. Treatment of bullous systemic lupus erythematosus. J Immunol Res. 2015;2015:167064. doi:10.1155/2015/167064
  • Rutnin S, Chanprapaph K. Vesiculobullous diseases in relation to lupus erythematosus. Clin Cosmet Investig Dermatol. 2019;12:653–667. doi:10.2147/CCID.S220906
  • Tankunakorn J, Sawatwarakul S, Vachiramon V, Chanprapaph K. Stevens-Johnson syndrome and toxic epidermal necrolysis-like lupus erythematosus. J Clin Rheumatol. 2019;25(5):224–231. doi:10.1097/RHU.0000000000000830
  • Chanprapaph K, Sawatwarakul S, Vachiramon V. A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients. Lupus. 2017;26(12):1278–1284. doi:10.1177/0961203317699714
  • Bernard P, Vaillant L, Labeille B, et al. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol. 1995;131(1):48–52. doi:10.1001/archderm.1995.01690130050009
  • Pons-Estel GJ, Quintana R, Alarcón GS, et al. A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients. Lupus. 2018;27(10):1753–1754. doi:10.1177/0961203318776104
  • Sprow G, Afarideh M, Dan J, Hedberg ML, Werth VP. Bullous systemic lupus erythematosus in females. Int J Womens Dermatol. 2022;8(3):e034. doi:10.1097/JW9.0000000000000034
  • Camisa C, Sharma HM. Vesiculobullous systemic lupus erythematosus. Report of two cases and a review of the literature. J Am Acad Dermatol. 1983;9(6):924–933. doi:10.1016/S0190-9622(83)70210-0
  • Malcangi G, Brandozzi G, Giangiacomi M, Zampetti M, Danieli MG. Bullous SLE: response to methotrexate and relationship with disease activity. Lupus. 2003;12(1):63–66. doi:10.1191/0961203303lu241cr
  • Camisa C. Vesiculobullous systemic lupus erythematosus. A report of four cases. J Am Acad Dermatol. 1988;18(1 Pt 1):93–100. doi:10.1016/S0190-9622(88)70014-6
  • de Risi-Pugliese T, Cohen Aubart F, Haroche J, et al. Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 New cases and a literature review of 118 cases. Semin Arthritis Rheum. 2018;48(1):83–89. doi:10.1016/j.semarthrit.2017.11.003
  • Sebaratnam DF, Murrell DF. Bullous systemic lupus erythematosus. Dermatol Clin. 2011;29(4):649–653. doi:10.1016/j.det.2011.06.002
  • Anyanwu CO, Ang CC, Werth VP. Oral mucosal involvement in bullous lupus. Arthritis Rheum. 2013;65(10):2622. doi:10.1002/art.38051
  • Akpabio AA, Otike-Odibi BI. Severe bullous systemic lupus erythematosus successfully treated with low dose rituximab: a case report from sub-Saharan Africa. Reumatismo. 2020;72(2):115–119. doi:10.4081/reumatismo.2020.1274
  • Chanprapaph K. Management of cutaneous lupus erythematosus. In: Chanprapaph K, editor. Cutaneous Lupus Erythematosus. Division of Dermatology, Department of Internal Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University; 2022:414–466.
  • Yell JA, Allen J, Wojnarowska F, Kirtschig G, Burge SM. Bullous systemic lupus erythematosus: revised criteria for diagnosis. Br J Dermatol. 1995;132(6):921–928. doi:10.1111/j.1365-2133.1995.tb16950.x
  • Qiao L, Zhang B, Zheng W, et al. Clusters of clinical and immunologic features in patients with bullous systemic lupus erythematosus: experience from a single-center cohort study in China. Orphanet J Rare Dis. 2022;17(1):290. doi:10.1186/s13023-022-02445-z
  • Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151–1159. doi:10.1136/annrheumdis-2018-214819
  • Heelan K, Al-Mohammedi F, Smith MJ, et al. Durable remission of pemphigus with a fixed-dose rituximab protocol. JAMA Dermatol. 2014;150(7):703–708. doi:10.1001/jamadermatol.2013.6739

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.